Sept 19 (Reuters) - BioXcel Therapeutics Inc BTAI.O :
* BIOXCEL THERAPEUTICS INC - PLAN TO REDUCE ITS WORKFORCE BY
15
EMPLOYEES, OR ABOUT 28% OF COMPANY'S HEADCOUNT
* BIOXCEL THERAPEUTICS: PLAN TO REDUCE WORKFORCE TO EXTEND
ITS
CASH RUNWAY, PRIORITIZE INVESTMENT ON CLINICAL DEVELOPMENT OF
ITS BXCL501
* BIOXCEL THERAPEUTICS INC - ESTIMATES IT WILL INCUR
AGGREGATE
CHARGES IN CONNECTION WITH CLINICAL PRIORITIZATION OF ABOUT $1.4
MILLION
* BIOXCEL THERAPEUTICS - SEES MAJORITY OF COSTS TO BE
INCURRED,
CLINICAL PRIORITIZATION IS EXPECTED TO BE COMPLETED, DURING
QUARTER ENDING DECEMBER 31
Source text for Eikon: ID:n0001104659-24-101176
Further company coverage: BTAI.O
((Reuters.Briefs@thomsonreuters.com;))